Enhabit (EHAB) to Release Quarterly Earnings on Wednesday

Enhabit (NYSE:EHAB - Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, November 6th. Analysts expect Enhabit to post earnings of $0.04 per share for the quarter. Enhabit has set its FY 2024 guidance at 0.190-0.370 EPS.Investors that wish to register for the company's conference call can do so using this link.

Enhabit (NYSE:EHAB - Get Free Report) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.07 EPS for the quarter, topping analysts' consensus estimates of $0.05 by $0.02. The firm had revenue of $260.60 million for the quarter, compared to analyst estimates of $265.99 million. Enhabit had a negative net margin of 0.84% and a positive return on equity of 1.61%. During the same quarter in the previous year, the business posted $0.04 EPS. On average, analysts expect Enhabit to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Enhabit Stock Down 0.7 %

Shares of Enhabit stock traded down $0.05 during trading hours on Wednesday, hitting $6.93. 80,759 shares of the company's stock traded hands, compared to its average volume of 587,300. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.73. Enhabit has a twelve month low of $6.89 and a twelve month high of $11.74. The stock has a 50 day simple moving average of $7.71 and a 200-day simple moving average of $8.71. The company has a market cap of $348.46 million, a PE ratio of -41.00 and a beta of 1.81.

Insiders Place Their Bets

In related news, Director Jeffrey Bolton purchased 5,000 shares of the business's stock in a transaction that occurred on Thursday, August 22nd. The shares were purchased at an average cost of $8.01 per share, with a total value of $40,050.00. Following the completion of the acquisition, the director now directly owns 78,877 shares of the company's stock, valued at approximately $631,804.77. The trade was a 0.00 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.90% of the stock is owned by company insiders.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.